Logo

News

Avion Pharmaceuticals, LLC., exhibitor at American College of Nurse Midwives Annual Meeting

June 6, 2013


Avion Pharmaceuticals, a specialty pharmaceutical company, is pleased to announce their recent participation in the American College of Nurse Midwives (ACNM ) Annual Meeting in Nashville, Tennessee from May 29th through June 2nd, 2013. ACNM is the professional association that represents certified nurse-midwives and certified midwives in the United States. With roots dating to 1929, ACNM is one of the oldest women’s health care organizations in the United States. Avion is proud to extend their support and partnership to this very important organization. Avion is focused on nurturing the health and nutritional needs of moms and babies.  Our goal is to provide products that deliver maximum benefit along the continuum of care in women’s lives.  Understanding women’s health and matching products that deliver positive support will help ensure improved lifestyles for women of all ages and life stages.

“The ACNM conference exceeded expectations for Avion. The high level of interest and interaction from the attendees and members of ACNM with our team of sales professionals was phenomenal. Our team was able to introduce two new products from our expanding portfolio to the Ob/Gyn community. We launched our new Prenate® Chewable™ product as well as our new iron supplement, FeRiva™”, stated Mike Sullivan, Vice President, Sales and Marketing, for Avion Pharmaceuticals.

“Avion Pharmaceuticals is excited to continue our support and partnerships with ACNM. The mutual focus on nurturing the health and nutritional needs of moms and babies is critical for both organizations” added Mark Pugh, CEO for Avion Pharmaceuticals.

acnm01  acnm02

About Avion Pharmaceuticals, LLC

Avion Pharmaceuticals, LLC., is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women’s Heath and Dermatology therapeutic areas.  Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs.  For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.